Article
Hepatitis B e antigen and hepatitis B surface antigen seroclearance with the emergence of lamivudine-associated and core mutations following CD4 elevation in a patient with hepatitis B and HIV.
Internal medicine (Tokyo, Japan) - 1 Jan 2015
Honda Takashi, Ishigami Masatoshi, Luo Fangqiong, Ishizu Yoji, Kuzuya Teiji, Hayashi Kazuhiko, Itoh Akihiro, Hirooka Yoshiki, Ishikawa Tetsuya, Nakano Isao, Katano Yoshiaki, Goto Hidemi
Abstract excerpt
Obtaining a better understanding of the mechanisms associated with hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) loss in patients with hepatitis B virus (HBV) is important for treating patients with chronic hepatitis B. We herein describe the case of a patient with HBV and human immunodeficiency virus whose chronic hepatitis was stabilized due to HBe and HBs seroconversion with the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.